Two top drugmakers, Sanofi and Celgene, agreed on Monday morning to shell out more than $20 billion combined, cinching deals for hemophilia drug maker Bioverativ and cell therapy developer Juno Therapeutics. Each agreement represents an expensive, risky bet on a crowded,... Read more »
The first gene therapy approved in the U.S. costs $850,000. Announcing the price on Jan. 3, its owner Spark Therapeutics held out the possibility of some relief, such as installment payments, or slim rebates if the drug, a one-time shot into... Read more »
It was a newsy week for Wisconsin’s innovation community. Catch up on some of the major happenings with these recent headlines:
—Exact Sciences’ (NASDAQ: EXAS) stock price finished the trading day on Wednesday down nearly 10 percent after the American... Read more »
May Mobility, the autonomous vehicle startup based in Ann Arbor, MI, had an action-packed 2017.
The company launched in January, completed a stint in the Y Combinator accelerator over the summer, put driverless shuttles on downtown Detroit streets through a small... Read more »
Karen DeSalvo has experience working in the public sector, but she’s hardly what you’d call a government bureaucrat.
DeSalvo, who is trained as a physician, served as the National Coordinator for Health Information Technology from 2014 to 2016 under President Barack... Read more »
[Updated 1/19/18, 2:47 pm. See below.] This week in Boston tech, we’re tracking legal action against a so-called “initial coin offering,” hiring sprees, a pair of acquisitions, several venture funding rounds, and more. Read on for details.
—Massachusetts securities... Read more »
Dallas—In healthcare, robots are being created to help with tasks like disinfecting hospital rooms or alerting patients when it’s time to take medications. A study at the Emotional Robotics Living Lab at the University of Texas at Arlington is even exploring... Read more »
The most overblown health story of the week was President Trump’s health exam. America learned Trump is in perfect health and has “great genes.” He takes Propecia. He doesn’t have heart problems, had a perfect cognitive test score, and is... Read more »
It’s not only people from other countries that are struggling harder to get into the United States these days, it seems. Technology from foreign nations may also be subject to stricter “immigration” rules.
The national origins of tech devices and services... Read more »